Factors Related to Corticosteroid Utilization in Preterm Birth

被引:3
作者
Gupta, Simi [1 ,2 ,3 ]
Ramin, Susan M. [1 ,2 ,3 ]
Tyson, Jon E. [4 ]
Lucas, Michael [1 ,2 ,3 ]
Vidaeff, Alex C. [1 ,2 ,3 ]
机构
[1] Univ Texas Houston Med Sch, Dept Obstet, Houston, TX USA
[2] Univ Texas Houston Med Sch, Dept Gynecol, Houston, TX USA
[3] Univ Texas Houston Med Sch, Dept Reprod Sci, Houston, TX USA
[4] Univ Texas Houston Med Sch, Dept Pediat, Houston, TX USA
关键词
Antenatal corticosteroids; preterm birth; utilization; ANTENATAL CORTICOSTEROIDS;
D O I
10.1055/s-0031-1274505
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
We sought to determine the rate of corticosteroid administration in preterm births in our institution and to describe factors associated with lack of corticosteroid exposure. We performed a retrospective case-control analysis. Of the 312 eligible women who delivered between 24 and 34 weeks' gestation, maternal corticosteroid administration was documented in 262 (84%) and no exposure in 50 (16%). A shorter admission to delivery interval (< 48 hours) decreased the likelihood of corticosteroid administration (odds ratio [OR] 0.11, 95% confidence interval [CI] 0.03 to 0.28, p < 0.001). Use of tocolytics was associated with a lower risk of corticosteroid nonexposure (OR 0.21, 95% CI 0.04 to 0.69, p = 0.006). Lack of prenatal care was associated with an increased risk of corticosteroid nonexposure (OR 3.18, 95% CI 1.01 to 9.15, p = 0.01). The likelihood of corticosteroid administration was also decreased by gestational ages at the upper limit of the spectrum (33 to 34 weeks; OR 0.22, 95% CI 0.09 to 0.53, p < 0.001). The latter effect persisted after exclusion of premature rupture of membranes cases. In our population, factors associated with no maternal corticosteroid administration were shorter interval between admission and delivery, gestational age at the upper limit of the currently recommended interval for corticosteroid administration, and lack of prenatal care.
引用
收藏
页码:413 / 417
页数:5
相关论文
共 8 条
[1]   Antenatal corticosteroids: Are incomplete courses beneficial? [J].
Elimian, A ;
Figueroa, R ;
Spitzer, AR ;
Ogburn, PL ;
Wiencek, V ;
Quirk, JG .
OBSTETRICS AND GYNECOLOGY, 2003, 102 (02) :352-355
[2]   Approaching NIH Guideline Recommended Care for Maternal-Infant Health: Clinical Failures to Use Recommended Antenatal Corticosteroids [J].
Howell, Elizabeth A. ;
Stone, Joanne ;
Kleinman, Lawrence C. ;
Inamdar, Sarla ;
Matseoane, Stephen ;
Chassin, Mark R. .
MATERNAL AND CHILD HEALTH JOURNAL, 2010, 14 (03) :430-436
[3]   Antenatal corticosteroid prescribing: A complete audit cycle [J].
Khoo, C. ;
Welsh, J. ;
Owen, P. .
JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2007, 27 (01) :33-36
[4]   Drug utilisation in very preterm infants: Any changes during the past decade [J].
Lindner, U. ;
Hilgendorff, A. ;
Frey, G. ;
Gortner, L. .
KLINISCHE PADIATRIE, 2008, 220 (04) :238-242
[5]   Guideline for the use of antenatal corticosteroids for fetal maturation [J].
Miracle, Xavier ;
Di Renzo, Gian Carlo ;
Stark, Ann ;
Fanaroff, Avroy ;
Carbonell-Estrany, Xavier ;
Saling, Erich .
JOURNAL OF PERINATAL MEDICINE, 2008, 36 (03) :191-196
[6]  
*NIH, 1994, NIH PUBL
[7]   Patterns of antenatal corticosteroid prescribing 1998-2004 [J].
Polyakov, Alex ;
Cohen, Saul ;
Baum, Marita ;
Trickey, Donna ;
Jolley, Damien ;
Wallace, Euan M. .
AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2007, 47 (01) :42-45
[8]  
Roberts S, 2006, COCHRANE DB SYST REV